130 related articles for article (PubMed ID: 38493672)
1. Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation.
Li B; Zu M; Jiang A; Cao Y; Wu J; Shahbazi MA; Shi X; Reis RL; Kundu SC; Xiao B
Biomaterials; 2024 Jun; 307():122530. PubMed ID: 38493672
[TBL] [Abstract][Full Text] [Related]
2. An Oral Nanomedicine Elicits
Zu M; Ma Y; Zhang J; Sun J; Shahbazi MA; Pan G; Reis RL; Kundu SC; Liu J; Xiao B
ACS Nano; 2024 Jan; 18(4):3651-3668. PubMed ID: 38241481
[TBL] [Abstract][Full Text] [Related]
3. Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer.
Wu J; Yi S; Cao Y; Zu M; Li B; Yang W; Shahbazi MA; Wan Y; Reis RL; Kundu SC; Shi X; Xiao B
Biomaterials; 2023 Nov; 302():122332. PubMed ID: 37801790
[TBL] [Abstract][Full Text] [Related]
4. Transient Mild Photothermia Improves Therapeutic Performance of Oral Nanomedicines with Enhanced Accumulation in the Colitis Mucosa.
Ma Y; Gou S; Zhu Z; Sun J; Shahbazi MA; Si T; Xu C; Ru J; Shi X; Reis RL; Kundu SC; Ke B; Nie G; Xiao B
Adv Mater; 2024 Apr; 36(14):e2309516. PubMed ID: 38085512
[TBL] [Abstract][Full Text] [Related]
5. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
6. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
[No Abstract] [Full Text] [Related]
7. Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model.
Ünal S; Can Öztürk S; Bilgiç E; Yanık H; Korkusuz P; Aktaş Y; Benito JM; Esendağlı G; Bilensoy E
Eur J Pharm Biopharm; 2021 Dec; 169():168-177. PubMed ID: 34700001
[TBL] [Abstract][Full Text] [Related]
8. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
9. Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy.
Lang T; Zhu R; Zhu X; Yan W; Li Y; Zhai Y; Wu T; Huang X; Yin Q; Li Y
Nat Commun; 2023 Aug; 14(1):4746. PubMed ID: 37550297
[TBL] [Abstract][Full Text] [Related]
10. Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer.
Zhang X; Song H; Canup BSB; Xiao B
Expert Opin Drug Deliv; 2020 Jun; 17(6):781-790. PubMed ID: 32237921
[TBL] [Abstract][Full Text] [Related]
11. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
[TBL] [Abstract][Full Text] [Related]
12. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy.
Zheng DW; Dong X; Pan P; Chen KW; Fan JX; Cheng SX; Zhang XZ
Nat Biomed Eng; 2019 Sep; 3(9):717-728. PubMed ID: 31332342
[TBL] [Abstract][Full Text] [Related]
13. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
[TBL] [Abstract][Full Text] [Related]
14. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment.
Nguyen-Trinh QN; Trinh KXT; Trinh NT; Vo VT; Li N; Nagasaki Y; Vong LB
Acta Biomater; 2022 Apr; 143():459-470. PubMed ID: 35235866
[TBL] [Abstract][Full Text] [Related]
15. Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids.
Ma H; Yu Y; Wang M; Li Z; Xu H; Tian C; Zhang J; Ye X; Li X
Apoptosis; 2019 Feb; 24(1-2):168-183. PubMed ID: 30506375
[TBL] [Abstract][Full Text] [Related]
16. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer.
Dong X; Pan P; Zheng DW; Bao P; Zeng X; Zhang XZ
Sci Adv; 2020 May; 6(20):eaba1590. PubMed ID: 32440552
[TBL] [Abstract][Full Text] [Related]
17. Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients
Li Y; Li ZX; Xie CY; Fan J; Lv J; Xu XJ; Lv J; Kuai WT; Jia YT
World J Gastroenterol; 2020 Dec; 26(48):7633-7651. PubMed ID: 33505141
[TBL] [Abstract][Full Text] [Related]
18. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
19. The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player?
Patel M; McAllister M; Nagaraju R; Badran SSFA; Edwards J; McBain AJ; Barriuso J; Aziz O
Crit Rev Oncol Hematol; 2022 Dec; 180():103856. PubMed ID: 36257533
[TBL] [Abstract][Full Text] [Related]
20. [Effects of probiotics on the intestinal microecological abnormalities and colorectal cancer of mice induced by high-fat diet].
He JD; Kong C; Gao RY; Yin F; Zhang Y; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):77-85. PubMed ID: 32594730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
